MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Stefan Ambs|Journal of Clinical Investigation|2013Cited by 469
ADHFE1 is a breast cancer oncogene and induces metabolic reprogrammingPrachi Mishra, Stefan Ambs|Journal of Clinical Investigation|2017Cited by 100
Inflammation and IGF‐I activate the Akt pathway in breast cancerRobyn L. Prueitt, Stefan Ambs|International Journal of Cancer|2006Cited by 92
Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen ResistanceNagireddy Putluri, Arun Sreekumar, Suman Kumar Maity et al.|Neoplasia|2014Cited by 90
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancerSharon A. Glynn, Stefan Ambs|BMC Cancer|2010Cited by 79